trial

tDCS to Enhance Cognitive Training in Schizophrenia

NCTId NCT01733602
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1, Phase 2 · Completed
Enrollment 52 (estimated)
Sponsored by The University of New South Wales
Primary completion 2016-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1, Phase 2
Status
Completed
Enrollment
52 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2012-11
Primary completion
2016-11
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
transcranial direct current stimulation

Sponsors

The University of New South WalesLead Sponsor

Sites

1 total
Sydney, Australia

Linked catalysts

1
tDCS to Enhance Cognitive Training in Schizophrenia — primary completion2016-11

Facts & assertions

4 sourced
Enrollment
52
Phase
PHASE1,PHASE2
Primary Completion Date
2016-11
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation
drug
lead_sponsor
The University of New South Wales
company
indication
Schizophrenia
indication
Schizophrenia
indication